The Democratic Republic of Congo is facing a high-risk Ebola outbreak caused by the rare Bundibugyo strain that has caused 177 deaths and 750 suspected cases.The WHO has escalated its national risk assessment as scientists race to initiate clinical trials for a new vaccine and test the antiviral drug Obeldesivir.Authorities have imposed strict public health restrictions in Ituri province to mitigate the spread of the virus among local populations.Healthcare teams continue to manage significant challenges regarding misinformation and regional civil instability while providing essential supportive care.